Literature DB >> 30460445

Needle and Syringe Programs and HIV-Related Risk Behaviors Among Men Who Inject Drugs: A Multilevel Analysis of Two Cities in Iran.

Mehdi Noroozi1, Alireza Noroozi2, Hamid Sharifi3, Gholamreza Ghaedamini Harouni4, Brandon D L Marshall5, Hesam Ghisvand1, Mostafa Qorbani6, Bahram Armoon7,8,9.   

Abstract

BACKGROUND: Many studies have found significant differences in HIV risk at the community and socioeconomic levels. However, few have considered variations in needle and syringe program (Jin et al., Oral Dis. 1;22(7):609-19) coverage and other community characteristics on HIV risk behaviors among people who inject drugs (PWIDs). Our objective was to study the relationship between individual factors and city-level characteristics (such as the city's coverage of harm reduction programs) on HIV risk behavior among PWID residing in two cities in Iran.
METHODS: The study was conducted from March to August 2016 in Tehran and Kermanshah provinces. One thousand PWID were recruited by a convenience sampling recruitment at local NSP Drop-in Centers (DIC) and through "snowball sampling" (i.e., using peers to refer participants to the study). We first examined associations between individual-level variables and HIV risk behaviors in bivariate analysis using the chi-square or Fisher's exact tests, as appropriate. Next, multi-level models were constructed to determine the amount of variability in HIV risk behavior that could be accounted for by individual- and community-level characteristics. Variables with p value < 0.2 were included in the multiple logistic regression model.
RESULTS: The results of the multilevel modeling showed that 32% of the variability in HIV risk behaviors among PWID could be explained by factors that differed between the two cities. When individual factors including higher HIV knowledge, access to NSP, higher HIV risk perception, and methamphetamine use were all included in the final model, 22% of the variability in HIV risk behaviors could be explained to city-level variables.
CONCLUSION: Findings suggest that expanding the accessibility (i.e., hours and venues) and community-level coverage of NSP services by establishing programs where PWID congregate might reduce HIV risk behavior among PWID.

Entities:  

Keywords:  Injection drugs; Iran; Multilevel analysis; Needle and syringe programs; Risk behaviors

Mesh:

Year:  2019        PMID: 30460445     DOI: 10.1007/s12529-018-9758-4

Source DB:  PubMed          Journal:  Int J Behav Med        ISSN: 1070-5503


  37 in total

1.  Ecological conceptual models: a framework and case study on ecosystem management for South Florida sustainability.

Authors:  J H Gentile; M A Harwell; W Cropper; C C Harwell; D DeAngelis; S Davis; J C Ogden; D Lirman
Journal:  Sci Total Environ       Date:  2001-07-02       Impact factor: 7.963

Review 2.  Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users.

Authors:  D R Gibson; N M Flynn; D Perales
Journal:  AIDS       Date:  2001-07-27       Impact factor: 4.177

3.  Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran.

Authors:  Saman Zamani; Masahiro Kihara; Mohammad Mehdi Gouya; Mohsen Vazirian; Masako Ono-Kihara; Emran Mohammad Razzaghi; Seiichi Ichikawa
Journal:  AIDS       Date:  2005-04-29       Impact factor: 4.177

4.  The social structural production of HIV risk among injecting drug users.

Authors:  Tim Rhodes; Merrill Singer; Philippe Bourgois; Samuel R Friedman; Steffanie A Strathdee
Journal:  Soc Sci Med       Date:  2005-03-19       Impact factor: 4.634

5.  Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.

Authors:  Bethany White; Carolyn Day; Louisa Degenhardt; Stuart Kinner; Craig Fry; Raimondo Bruno; Jennifer Johnston
Journal:  Drug Alcohol Depend       Date:  2005-12-15       Impact factor: 4.492

6.  Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs.

Authors:  Gary Marks; Nicole Crepaz; J Walton Senterfitt; Robert S Janssen
Journal:  J Acquir Immune Defic Syndr       Date:  2005-08-01       Impact factor: 3.731

7.  Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of san francisco men who have sex with men.

Authors:  Grant Colfax; Thomas J Coates; Marla J Husnik; Yijian Huang; Susan Buchbinder; Beryl Koblin; Margaret Chesney; Eric Vittinghoff
Journal:  J Urban Health       Date:  2005-02-28       Impact factor: 3.671

8.  Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users.

Authors:  F Molitor; J D Ruiz; N Flynn; J N Mikanda; R K Sun; R Anderson
Journal:  Am J Drug Alcohol Abuse       Date:  1999-08       Impact factor: 3.829

9.  Perception of risk of HIV/AIDS and sexual behaviour in Kenya.

Authors:  Priscilla A Akwara; Nyovani Janet Madise; Andrew Hinde
Journal:  J Biosoc Sci       Date:  2003-07

10.  Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: a cross-sectional study.

Authors:  Mohsen Vazirian; Bijan Nassirimanesh; Saman Zamani; Masako Ono-Kihara; Masahiro Kihara; Shahrzad Mortazavi Ravari; Mohammad Mehdi Gouya
Journal:  Harm Reduct J       Date:  2005-10-07
View more
  5 in total

1.  Getting to Zero: Targeting Psychiatric Comorbidities as Drivers of the HIV/AIDS Epidemic.

Authors:  Adam W Carrico
Journal:  Int J Behav Med       Date:  2019-02

2.  Dental caries and periodontal disease among people who use drugs: a systematic review and meta-analysis.

Authors:  Mohsen Yazdanian; Bahram Armoon; Alireza Noroozi; Rasool Mohammadi; Amir-Hosein Bayat; Elahe Ahounbar; Peter Higgs; Hormoz Sanaei Nasab; Azadeh Bayani; Morteza Hemmat
Journal:  BMC Oral Health       Date:  2020-02-10       Impact factor: 2.757

3.  Prevalence and associates of non-fatal overdose among people who inject drugs in Saveh, Iran.

Authors:  Bahram Armoon; Mark D Griffiths; Azadeh Bayani; Rasool Mohammadi; Elaheh Ahounbar
Journal:  Addict Sci Clin Pract       Date:  2022-08-04

4.  Substance Use Disorder, Intravenous Injection, and HIV Infection: A Review.

Authors:  Shao-Cheng Wang; Brion Maher
Journal:  Cell Transplant       Date:  2019-09-24       Impact factor: 4.064

5.  Methamphetamine use and HIV risk behavior among men who inject drugs: causal inference using coarsened exact matching.

Authors:  Mehdi Noroozi; Peter Higgs; Alireza Noroozi; Bahram Armoon; Bentolhoda Mousavi; Rosa Alikhani; Mohammad Rafi Bazrafshan; Ali Nazeri Astaneh; Azadeh Bayani; Ladan Fattah Moghaddam
Journal:  Harm Reduct J       Date:  2020-09-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.